# Measurable Residual Disease Detection Using Tumor-Informed ctDNA Surveillance After Curative-Intent Treatment in HPV-Independent Squamous Cell Carcinoma of the Head and Neck

> **NCT06744296** · — · RECRUITING · sponsor: **Massachusetts Eye and Ear Infirmary** · enrollment: 75 (estimated)

## Conditions studied

- Squamous Cell Carcinoma of Head and Neck

## Interventions

- **OTHER:** Blood Draws and Tissue Sample(s)

## Key facts

- **NCT ID:** NCT06744296
- **Lead sponsor:** Massachusetts Eye and Ear Infirmary
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-02-03
- **Primary completion:** 2027-01-06
- **Final completion:** 2029-01-06
- **Target enrollment:** 75 (ESTIMATED)
- **Last updated:** 2025-05-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06744296

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06744296, "Measurable Residual Disease Detection Using Tumor-Informed ctDNA Surveillance After Curative-Intent Treatment in HPV-Independent Squamous Cell Carcinoma of the Head and Neck". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06744296. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*